Literature DB >> 15591019

RNA interference and the use of small interfering RNA to study gene function in mammalian systems.

I Bantounas1, L A Phylactou, J B Uney.   

Abstract

In the past 2 years, extraordinary developments in RNA interference (RNAi)-based methodologies have seen small interfering RNAs (siRNA) become the method of choice for researchers wishing to target specific genes for silencing. In this review, an historic overview of the biochemistry of the RNAi pathway is described together with the latest advances in the RNAi field. Particular emphasis is given to strategies by which siRNAs are used to study mammalian gene function. In this regard, the use of plasmid-based and viral vector-based systems to mediate long-term RNAi in vitro and in vivo are described. However, recent work has shown that non-specific silencing effects and activation of the interferon response may occur following the use of some siRNA and delivery vector combinations. Future goals must therefore be to understand the mechanisms by which siRNA delivery leads to unwanted gene silencing effects in cells and, in this way, RNAi technology can reach its tremendous potential as a scientific tool and ultimately be used for therapeutic purposes.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15591019     DOI: 10.1677/jme.1.01582

Source DB:  PubMed          Journal:  J Mol Endocrinol        ISSN: 0952-5041            Impact factor:   5.098


  32 in total

1.  Steric restrictions of RISC in RNA interference identified with size-expanded RNA nucleobases.

Authors:  Armando R Hernández; Larryn W Peterson; Eric T Kool
Journal:  ACS Chem Biol       Date:  2012-06-12       Impact factor: 5.100

2.  Overexpression of SUMO-1 in hepatocellular carcinoma: a latent target for diagnosis and therapy of hepatoma.

Authors:  Wu-Hua Guo; Li-Hua Yuan; Zhi-Hua Xiao; Dan Liu; Ji-Xiang Zhang
Journal:  J Cancer Res Clin Oncol       Date:  2010-05-26       Impact factor: 4.553

3.  An inducible T7 RNA polymerase-dependent plasmid system.

Authors:  Matthias Hamdorf; Heide Muckenfuss; Ulrich Tschulena; Stephan Pleschka; Ralf Sanzenbacher; Klaus Cichutek; Egbert Flory
Journal:  Mol Biotechnol       Date:  2006-05       Impact factor: 2.695

4.  MicroRNAs and osmotic regulation.

Authors:  James B Uney; Stafford L Lightman
Journal:  Proc Natl Acad Sci U S A       Date:  2006-10-09       Impact factor: 11.205

5.  Essential role of obscurin in cardiac myofibrillogenesis and hypertrophic response: evidence from small interfering RNA-mediated gene silencing.

Authors:  Andrei B Borisov; Sarah B Sutter; Aikaterini Kontrogianni-Konstantopoulos; Robert J Bloch; Margaret V Westfall; Mark W Russell
Journal:  Histochem Cell Biol       Date:  2005-10-05       Impact factor: 4.304

6.  A rat model of intravesical delivery of small interfering RNA for studying urinary carcinoma.

Authors:  Carl-Jørgen Arum; Yosuke Kodama; Natale Rolim; Marius Widerøe; Endre Anderssen; Trond Viset; Marit Otterlei; Steinar Lundgren; Duan Chen; Chun-Mei Zhao
Journal:  World J Urol       Date:  2010-04-08       Impact factor: 4.226

7.  Adipogenic differentiation is not influenced by lentivirus-mediated shRNA targeting the SOCS3 gene in adipose-derived stromal cells.

Authors:  Li Liu; Hailun Gu; Jun Yang; Shuang Ma; Fei Yu; Yahao Ren; Li An
Journal:  Mol Biol Rep       Date:  2009-08-20       Impact factor: 2.316

8.  siRNA specific to Pdx-1 disturbed the formation of the islet in early zebrafish embryos.

Authors:  Shen Chen; Jintao Huang; Guangming Yuan
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2007-12

9.  RNAi and cancer: Implications and applications.

Authors:  Maen Abdelrahim; Stephen Safe; Cheryl Baker; Ala Abudayyeh
Journal:  J RNAi Gene Silencing       Date:  2006-02-28

10.  Oral cancer overexpressed 1 (ORAOV1) regulates cell cycle and apoptosis in cervical cancer HeLa cells.

Authors:  Lu Jiang; Xin Zeng; Zhi Wang; Ning Ji; Yu Zhou; Xianting Liu; Qianming Chen
Journal:  Mol Cancer       Date:  2010-01-28       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.